Related references
Note: Only part of the references are listed.Association between alopecia areata, anxiety, and depression: A systematic review and meta-analysis
Jean-Phillip Okhovat et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2023)
PF-06651600, a Dual JAK3/TEC Family Kinase Inhibitor
Hua Xu et al.
ACS CHEMICAL BIOLOGY (2019)
The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a TYK2/JAK1 Inhibitor (PF-06700841) in Healthy Subjects and Patients With Plaque Psoriasis
Christopher Banfield et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2018)
An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis
A. Jabbari et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Alopecia areata is associated with impaired health-related quality of life: A survey of affected adults and children and their families
Lucy Y. Liu et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2018)
Dual Inhibition of TYK2 and JAK1 for the Treatment of Autoimmune Diseases: Discovery of ((S)-2,2-Difluorocyclopropyl)((1R,5S)-3-(2-(1-methyl-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone (PF-06700841)
Andrew Fensome et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Alopecia areata
C. Herbert Pratt et al.
NATURE REVIEWS DISEASE PRIMERS (2017)
The Utility and Validity of the Alopecia Areata Symptom Impact Scale in Measuring Disease-Related Symptoms and their Effect on Functioning
Tito R. Mendoza et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2017)
Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective Inhibition
Jean-Baptiste Telliez et al.
ACS CHEMICAL BIOLOGY (2016)
Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
Milene Kennedy Crispin et al.
JCI INSIGHT (2016)
Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata
Julian Mackay-Wiggan et al.
JCI INSIGHT (2016)
Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition
Luzhou Xing et al.
NATURE MEDICINE (2014)
Development of the Alopecia Areata Symptom Impact Scale
Tito R. Mendoza et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY SYMPOSIUM PROCEEDINGS (2013)
Medical Progress Alopecia Areata
Amos Gilhar et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Collapse of Immune Privilege in Alopecia Areata: Coincidental or Substantial?
Amos Gilhar
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Cytokine signaling modules in inflammatory responses
John J. O'Shea et al.
IMMUNITY (2008)
The JAK-STAT signaling pathway: Input and output intergration
Peter J. Murray
JOURNAL OF IMMUNOLOGY (2007)
Profile of 513 patients with alopecia areata: associations of disease subtypes with atopy, autoimmune disease and positive family history
C. Goh et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2006)
Alopecia areata: A long term follow-up study of 191 patients
Antonella Tosti et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2006)
Alopecia areata investigational assessment guidelines - Part II
EA Olsen et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2004)
Share Paper
